Cargando…
Orally ingestible medical devices for gut engineering
Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255201/ https://www.ncbi.nlm.nih.gov/pubmed/32416112 http://dx.doi.org/10.1016/j.addr.2020.05.004 |
_version_ | 1783539687151894528 |
---|---|
author | Mandsberg, Nikolaj Kofoed Christfort, Juliane Fjelrad Kamguyan, Khorshid Boisen, Anja Srivastava, Sarvesh Kumar |
author_facet | Mandsberg, Nikolaj Kofoed Christfort, Juliane Fjelrad Kamguyan, Khorshid Boisen, Anja Srivastava, Sarvesh Kumar |
author_sort | Mandsberg, Nikolaj Kofoed |
collection | PubMed |
description | Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in the GI tract, real-time imaging and sensing of gut biomarkers. Equipped with uni-direction release, or self-propulsion, or origami design, these microdevices are breaking the barriers associated with drug delivery, including biologics, across the GI tract. Further, on-board microelectronics allow imaging and sensing of gut tissue and biomarkers, providing a more comprehensive understanding of underlying pathophysiological conditions. We provide an overview of recent advances in orally ingestible medical devices towards drug delivery, imaging and sensing. Challenges associated with gut microenvironment, together with various activation/actuation modalities of medical devices for micromanipulation of the gut are discussed. We have critically examined the relationship between materials–device design–pharmacological responses with respect to existing regulatory guidelines and provided a clear roadmap for the future. |
format | Online Article Text |
id | pubmed-7255201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72552012020-05-28 Orally ingestible medical devices for gut engineering Mandsberg, Nikolaj Kofoed Christfort, Juliane Fjelrad Kamguyan, Khorshid Boisen, Anja Srivastava, Sarvesh Kumar Adv Drug Deliv Rev Article Orally ingestible medical devices provide significant advancement for diagnosis and treatment of gastrointestinal (GI) tract-related conditions. From micro- to macroscale devices, with designs ranging from very simple to complex, these medical devices can be used for site-directed drug delivery in the GI tract, real-time imaging and sensing of gut biomarkers. Equipped with uni-direction release, or self-propulsion, or origami design, these microdevices are breaking the barriers associated with drug delivery, including biologics, across the GI tract. Further, on-board microelectronics allow imaging and sensing of gut tissue and biomarkers, providing a more comprehensive understanding of underlying pathophysiological conditions. We provide an overview of recent advances in orally ingestible medical devices towards drug delivery, imaging and sensing. Challenges associated with gut microenvironment, together with various activation/actuation modalities of medical devices for micromanipulation of the gut are discussed. We have critically examined the relationship between materials–device design–pharmacological responses with respect to existing regulatory guidelines and provided a clear roadmap for the future. Elsevier B.V. 2020 2020-05-13 /pmc/articles/PMC7255201/ /pubmed/32416112 http://dx.doi.org/10.1016/j.addr.2020.05.004 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mandsberg, Nikolaj Kofoed Christfort, Juliane Fjelrad Kamguyan, Khorshid Boisen, Anja Srivastava, Sarvesh Kumar Orally ingestible medical devices for gut engineering |
title | Orally ingestible medical devices for gut engineering |
title_full | Orally ingestible medical devices for gut engineering |
title_fullStr | Orally ingestible medical devices for gut engineering |
title_full_unstemmed | Orally ingestible medical devices for gut engineering |
title_short | Orally ingestible medical devices for gut engineering |
title_sort | orally ingestible medical devices for gut engineering |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255201/ https://www.ncbi.nlm.nih.gov/pubmed/32416112 http://dx.doi.org/10.1016/j.addr.2020.05.004 |
work_keys_str_mv | AT mandsbergnikolajkofoed orallyingestiblemedicaldevicesforgutengineering AT christfortjulianefjelrad orallyingestiblemedicaldevicesforgutengineering AT kamguyankhorshid orallyingestiblemedicaldevicesforgutengineering AT boisenanja orallyingestiblemedicaldevicesforgutengineering AT srivastavasarveshkumar orallyingestiblemedicaldevicesforgutengineering |